Brookstone Capital Management

Position in NBIX — Neurocrine Biosciences Inc

CIK 1599584 WHEATON, IL

Position in NBIX

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$788,935

+$123,648 QoQ

Shares Held

4,681

-7.3% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#429

of 772 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Brookstone Capital Management holds $6,325,490 across 5 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (12.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	5,944	$3,220,637
2	HROW	Harrow, Inc.	31,153	$1,323,067
3	NBIX	Neurocrine Biosciences Inc This page	4,681	$788,935
4	ELAN	Elanco Animal Health Inc	31,934	$785,895
5	ZTS	Zoetis Inc.	2,880	$206,956

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$788,935	4,681	-7.3%	Shares	Sole	2026-07-15
2026-03-31	$665,287	5,050	+23.1%	Shares	Sole	2026-04-16
2025-12-31	$581,644	4,101	-5.8%	Shares	Sole	2026-01-15
2025-09-30	$611,074	4,353	—	Shares	Sole	2025-10-15
No filing history on record for this holder in this stock.